Skip to main content
Knowledge-Pathway-Hero-image

Improved Automation Reduces Technician Interaction in IHC Staining

David Newell
David Newell MBA, HT(ASCP)CM

Each commercially available automated immunohistochemistry (IHC) platform has strategic design differences that produce advantages and disadvantages. Understanding those differences can help match the demands of testing volumes, turnaround time, standardization, and labor savings to the appropriate automated instrumentation.1 The workflow of your laboratory can help determine which platform would best fit your needs. Some automated IHC platforms are more suited to batch staining, where pending lists are pulled at scheduled times throughout the day, and others to more individualized staining, that is, managing individual cases ordered in real time.

DOWNLOAD THE CASE STUDY NOW!


About the presenter

David Newell
David Newell , MBA, HT(ASCP)CM

David Newell has been working in the field of Laboratory Medicine for over 20 years. He has experience working on the Laboratory Informatics Implementation team, leading installations across North America. Before joining Leica Biosystems, he served in several roles at a large reference laboratory in Arizona, including over eight years as a Histotechnologist. He has experience managing an Anatomic Pathology Department for a level 1 trauma center and a dermatology laboratory. David holds a Bachelor of Science in Kinesiology and Master of Business Administration and Histologic Technician (HT) certification through the American Society for Clinical Pathology (ASCP). He received his Six Sigma and Lean training through Quest Diagnostics in 2002 and 2010, respectively.

Leica Biosystems content is subject to the Leica Biosystems website terms of use, available at: Legal Notice. The content, including webinars, training presentations and related materials is intended to provide general information regarding particular subjects of interest to health care professionals and is not intended to be, and should not be construed as, medical, regulatory or legal advice. The views and opinions expressed in any third-party content reflect the personal views and opinions of the speaker(s)/author(s) and do not necessarily represent or reflect the views or opinions of Leica Biosystems, its employees or agents. Any links contained in the content which provides access to third party resources or content is provided for convenience only.

For the use of any product, the applicable product documentation, including information guides, inserts and operation manuals should be consulted.

Copyright © 2024 Leica Biosystems division of Leica Microsystems, Inc. and its Leica Biosystems affiliates. All rights reserved. LEICA and the Leica Logo are registered trademarks of Leica Microsystems IR GmbH.